The assessment of rheumatoid arthritis. a study based on measurements of the serum acute-phase reactants
McConkey, B.; Crockson, R.A.; Crockson, A.P.
Quarterly Journal of Medicine 41(162): 115-125
1972
ISSN/ISBN: 0033-5622 PMID: 4561431 Document Number: 55006
Document emailed within 1 workday
Related Documents
Hansen, T.M.; Manthorpe, R.; Kofod, B.; Andreassen, T.; Oxlund, H.; Lorenzen, I.B. 1976: Penicillamine in rheumatoid arthritis. Connective tissue changes and alterations in serum copper and phase reactants in relation to clinical improvement Journal of Rheumatology 3(4): 367-374Berdnik-Gortan, K.; Bjelinski, D. 1999: Effect of combination therapy and nonsteroidal antirheumatic agents on acute phase reactants in patients with rheumatoid arthritis Reumatizam 46(1): 12-16
van Leeuwen, M.A.; van der Heijde, D.M.; van Rijswijk, M.H.; Houtman, P.M.; van Riel, P.L.; van de Putte, L.B.; Limburg, P.C. 1994: Interrelationship of outcome measures and process variables in early rheumatoid arthritis. A comparison of radiologic damage, physical disability, joint counts, and acute phase reactants Journal of Rheumatology 21(3): 425-429
Shiokawa, Y. 1987: Clinical study of the acute phase reaction. Acute phase proteins and a chronic inflammation, rheumatoid arthritis Nihon Rinsho. Japanese Journal of Clinical Medicine 45(5): 1068-1075
Paulus, H.E.; Ramos, B.; Wong, W.K.; Ahmed, A.; Bulpitt, K.; Park, G.; Sterz, M.; Clements, P. 1999: Equivalence of the acute phase reactants C-reactive protein, plasma viscosity, and Westergren erythrocyte sedimentation rate when used to calculate American College of Rheumatology 20% improvement criteria or the Disease Activity Score in patients with early rheumatoid arthritis. Western Consortium of Practicing Rheumatologists Journal of Rheumatology 26(11): 2324-2331
Taniuchi, K.; Chifu, K.; Hayashi, N.; Nakamachi, Y.; Yamaguchi, N.; Miyamoto, Y.; Doi, K.; Baba, S.; Uchida, Y.; Tsukada, Y.; Sugimori, T. 1981: A new enzymatic method for the determination of sialic acid in serum and its application for a marker of acute phase reactants Kobe Journal of Medical Sciences 27(3): 91-102
Kumon, Y.; Loose, L.D.; Birbara, C.A.; Sipe, J.D. 1997: Rheumatoid arthritis exhibits reduced acute phase and enhanced constitutive serum amyloid A protein in synovial fluid relative to serum. A comparison with C-reactive protein Journal of Rheumatology 24(1): 14-19
Goldstein, R.; Duff, S.; Karsh, J. 1987: Functional assessment and symptoms of rheumatoid arthritis in relation to menstrual cycle phase Journal of Rheumatology 14(2): 395-397
Grieble, H.; Bach, G.; Anderson, T.; Zschocke, R. 1971: Standardization of the latex fixation test for the demonstration of the rheumatoid factor. 3. Nature of the rheumatoid factor in normal serum, in serum of patients with rheumatoid arthritis, and in serum of the aged Acta Biologica et Medica Germanica 26(1): 185-191
Philip, A.G. 1984: White blood cells and acute phase reactants in neonatal sepsis Pediatrie 39(5): 371-378
Galeazzi, M.; Morozzi, G.; Veronesi, M.; Ronconi, S.; Magi, B.; Bini, L.; Marcolongo, R. 1995: Usefulness of the determination of C reactive protein and other acute phase proteins in rheumatoid arthritis Recenti Progressi in Medicina 86(11): 456-462
Dobryszycka, W.; Gerber, J.; Zuwała-Jagiełło, J.; Ujec, M. 1991: Acute phase reactants and circulating immune complexes in patients with ovarian carcinoma Archivum Immunologiae et Therapiae Experimentalis 39(1-2): 41-50
Ma, J.; Wang, X.; Mo, Y.; Chen, L.; Zheng, D.; Wei, X.; Dai, L. 2015: Value of serum matrix metalloproteinase-3 in the assessment of active disease in patients with rheumatoid arthritis Zhonghua Yi Xue Za Zhi 95(47): 3823-3828
Marhoffer, W.; Schatz, H.; Stracke, H.; Ullmann, J.; Schmidt, K.; Federlin, K. 1991: Serum osteocalcin levels in rheumatoid arthritis: a marker for accelerated bone turnover in late onset rheumatoid arthritis Journal of Rheumatology 18(8): 1158-1162
Yildirim, K.; Karatay, S.; Melikoglu, M.Alkan.; Gureser, G.; Ugur, M.; Senel, K. 2005: Associations between acute phase reactant levels and disease activity score (DAS28) in patients with rheumatoid arthritis Annals of Clinical and Laboratory Science 34(4): 423-426
Artom, A.; Gandolfo, N. 2004: Idiopathic retroperitoneal fibrosis: a case report without increased levels of acute-phase reactants. Noninvasive diagnosis and treatment Annali Italiani di Medicina Interna: Organo Ufficiale Della Societa Italiana di Medicina Interna 19(1): 50-53
Nishimoto, N.; Yoshizaki, K.; Maeda, K.; Kuritani, T.; Deguchi, H.; Sato, B.; Imai, N.; Suemura, M.; Kakehi, T.; Takagi, N.; Kishimoto, T. 2003: Toxicity, pharmacokinetics, and dose-finding study of repetitive treatment with the humanized anti-interleukin 6 receptor antibody MRA in rheumatoid arthritis. Phase I/II clinical study Journal of Rheumatology 30(7): 1426-1435
Luis M. Amezcua-Guerra; Springall, R.; Arrieta, A.A.-Alvarado; Verónica Rodriguez; Rivera, E.-Martinez; Castillo, D.-Martinez; Bojalil, R. 2011: C-Reactive Protein and Complement Components but not Other Acute-Phase Reactants Discriminate Between Clinical Subsets and Organ Damage in Systemic Lupus Erythematosus Clinical Laboratory 57(7-8): 607-613
Henrard, J.C.; Bennett, P.H.; Burch, T.A. 1974: Epidemiology of rheumatoid arthritis. Evaluation of the so-called Rome and new York criteria for the diagnosis of rheumatoid arthritis in a population study Revue du Rhumatisme et des Maladies Osteo-Articulaires 41(11): 675-683
Westhovens, Ré.; Houssiau, Fédéric.; Joly, J.; Everitt, D.E.; Zhu, Y.; Sisco, D.; Van Hartingsveldt, B.; Mascelli, M.Ann.; Graham, M.A.; Durez, P.; Bouman-Thio, E. 2006: A phase I study assessing the safety, clinical response, and pharmacokinetics of an experimental infliximab formulation for subcutaneous or intramuscular administration in patients with rheumatoid arthritis Journal of Rheumatology 33(5): 847-853